# Oral Contraceptive During Menopausal Transition

> **NCT01414530** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 52 (estimated)

## Conditions studied

- Perimenopause

## Interventions

- **DRUG:** oral contraceptive
- **DRUG:** NSAID

## Key facts

- **NCT ID:** NCT01414530
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2014-06
- **Final completion:** —
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2013-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01414530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01414530, "Oral Contraceptive During Menopausal Transition". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01414530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*